AzTrials
AzTrials

HIVNCT01465607

Implementation of an Efficacious Intervention for High Risk Women in Mexico

A study testing Mujer Segura and CENSIDA counseling program in people with HIV and Syphilis, run by University of California, San Diego at 4 sites in Mexico.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This project seeks to determine the personal and organizational conditions that are most conducive to the widespread adoption by community-based organizations (CBOs) of effective programs for reducing the spread of HIV and other sexually transmitted infections (STIs). Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
HIV, Syphilis, Gonorrhea
What is being tested?
Mujer Segura and CENSIDA counseling program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,228 participants
Where
4 sitesMexico
Study dates
Nov 2011to Apr 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • At least 18 years of age
  • Self-identify as female sex worker
  • Exchanged sex for money, drugs, shelter, or other benefit in last 2 months
  • Had unprotected anal or vaginal sex with male client at least once in last 2 months
  • Agree to be tested for HIV \& STIs at baseline and 6-month follow-u0

Who cannot join

  • Previous positive HIV test result

Trial locations and contacts

4 sites in 1 country.

Mexico4 sites
  • CSM Guadalajara

    Guadalajara, Jalisco, 44270

  • Centro de Servicios Medicos (CSM) Revolucion

    Mexico City, D.f., 06080

  • CSM Naranjos

    Naranjos, Veracruz, 92300

  • CSM Veracruz

    Veracruz, Veracruz, 91910

Other trials in Mexico

About this study

This project seeks to determine the personal and organizational conditions that are most conducive to the widespread adoption by community-based organizations (CBOs) of effective programs for reducing the spread of HIV and other sexually transmitted infections (STIs). Taking a brief, single-session counseling program (called "Mujer Segura") that has been proven effective in reducing HIV and STIs in female sex workers who work in Mexican cities along the U.S. border, this project will study the implementation of the program in CBOs in 12 additional cities throughout Mexico to determine how best to ensure that the program remains true to the original model and retains its effectiveness. Mexico has been chosen because HIV is a global problem that respects no international borders, and because HIV prevention programs that can be implemented in settings with limited resources are urgently needed in many parts of the world.

Being tested
Mujer Segura, CENSIDA counseling program
Keywords
Condom use
Medical subject headings
Syphilis, Gonorrhea, Chlamydia Infections

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mujer SeguraBehavioural

    Brief (35-minute) counseling intervention using techniques from Motivational Interviewing and principles of social cognitive theory (SCT) and theory of reasoned action (TRA).

  • CENSIDA counseling programBehavioural

    Didactic HIV and STI counseling involving some personal risk assessment and presenting appropriate information on methods of transmission and for avoiding or reducing the risk of infection. Based on a counseling manual disseminated by CENSIDA, Mexico's federal HIV-AIDS prevention agency.

Study groups in NCT01465607
Study groupRoleWhat they receive
Theory-based counseling (Mujer Segura)ExperimentalWill consist of 40 FSWs at each of 12 clinics, randomized into this condition from a pool of 80 eligible participants.
Receives: Behavioral: Mujer Segura
CENSIDA counseling program (didactic)Active comparatorWill consist of 40 FSWs at each of 12 clinics, randomized into this condition from a pool of 80 eligible participants.
Receives: Behavioral: CENSIDA counseling program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Reduction in HIV and STI incidence relative to control group

    Female sex worker (FSW) participants will be tested at baseline and 6-month follow-up for HIV, syphilis, gonorrhea, and Chlamydia. Incidence rates for all infections at 6-month follow-up will be compared between the theory-based Mujer Segura group (N=40 per clinic) and the standard counseling group (N=40 per clinic).

    Measured: 6 months

  2. Reduction in number of unprotected sex acts relative to control group

    Female sex worker (FSW) participants will be assessed at baseline and 6-month follow-up using self-report measures of frequency of protected and unprotected sex acts with male clients. Changes in frequency at 6-month follow-up will be compared between the theory-based Mujer Segura group (N=40 per clinic) and the standard counseling group (N=40 per clinic).

    Measured: 6 months

Secondary outcomes (1)
  1. Fidelity to Mujer Segura intervention model

    Counselors at each CBO will be assessed for their fidelity to the intervention protocol and assigned a numerical score. This number will be used to determine possible correlations between levels of fidelity and the efficacy of the Mujer Segura intervention at each clinic.

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Nov 2011 (estimated)
  2. Study startNov 2011
  3. Primary completionApr 2015
  4. Study completionApr 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
1,228 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01465607
Sponsor's protocol ID
R01MH087054
Other IDs
R01MH087054
Status last verified
May 2015
First submitted
2 Nov 2011
Last updated
27 May 2015
Results posted
No
Data monitoring committee
No

Publications

  • Pitpitan EV, Semple SJ, Aarons GA, Palinkas LA, Chavarin CV, Mendoza DV, Magis-Rodriguez C, Staines H, Patterson TL. Factors associated with program effectiveness in the implementation of a sexual risk reduction intervention for female sex workers across Mexico: Results from a randomized trial. PLoS One. 2018 Sep 11;13(9):e0201954. doi: 10.1371/journal.pone.0201954. eCollection 2018.

    PubMed 30204761
  • Patterson TL, Semple SJ, Chavarin CV, Mendoza DV, Santos LE, Chaffin M, Palinkas LA, Strathdee SA, Aarons GA. Implementation of an efficacious intervention for high risk women in Mexico: protocol for a multi-site randomized trial with a parallel study of organizational factors. Implement Sci. 2012 Oct 29;7:105. doi: 10.1186/1748-5908-7-105.

    PubMed 23107285

Questions about this trial

What is this clinical trial studying?

A study testing Mujer Segura and CENSIDA counseling program in people with HIV and Syphilis, run by University of California, San Diego at 4 sites in Mexico.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 May 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Mexico. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Reduction in HIV and STI incidence relative to control group (time frame: 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01465607, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 May 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in